Copyright
©The Author(s) 2023.
Artif Intell Gastroenterol. Sep 8, 2023; 4(2): 36-47
Published online Sep 8, 2023. doi: 10.35712/aig.v4.i2.36
Published online Sep 8, 2023. doi: 10.35712/aig.v4.i2.36
Figure 1 Patient selection flowchart for drug-induced liver injury assessment.
ALT: Alanine aminotransferase; COVID-19: Coronavirus disease 2019; DILI: Drug-induced liver injury; EMR: Electronic medical records; RUCAM: Roussel Uclaf causality assessment method; ULN: Upper limit of normal.
- Citation: Ortiz GX, Ulbrich AHDPS, Lenhart G, dos Santos HDP, Schwambach KH, Becker MW, Blatt CR. Drug-induced liver injury and COVID-19: Use of artificial intelligence and the updated Roussel Uclaf Causality Assessment Method in clinical practice. Artif Intell Gastroenterol 2023; 4(2): 36-47
- URL: https://www.wjgnet.com/2644-3236/full/v4/i2/36.htm
- DOI: https://dx.doi.org/10.35712/aig.v4.i2.36